CATALOGO DEI PRODOTTI DELLA RICERCA

Granata, Simona
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.648
NA - Nord America 2.168
AS - Asia 1.430
SA - Sud America 225
AF - Africa 26
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 3
Totale 6.504
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.130
RU - Federazione Russa 999
GB - Regno Unito 557
CN - Cina 540
SG - Singapore 498
IT - Italia 260
SE - Svezia 209
BR - Brasile 178
FR - Francia 166
IE - Irlanda 137
HK - Hong Kong 125
DE - Germania 122
VN - Vietnam 119
FI - Finlandia 87
ID - Indonesia 31
UA - Ucraina 26
KR - Corea 24
AR - Argentina 23
BE - Belgio 18
AT - Austria 17
IN - India 16
TR - Turchia 16
CA - Canada 14
MX - Messico 13
JP - Giappone 12
EC - Ecuador 10
ZA - Sudafrica 10
PL - Polonia 9
ES - Italia 7
NL - Olanda 6
RO - Romania 6
IQ - Iraq 5
BD - Bangladesh 4
IL - Israele 4
MY - Malesia 4
PK - Pakistan 4
UZ - Uzbekistan 4
AU - Australia 3
CH - Svizzera 3
DK - Danimarca 3
EU - Europa 3
GR - Grecia 3
KE - Kenya 3
KG - Kirghizistan 3
MA - Marocco 3
PY - Paraguay 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
BH - Bahrain 2
CL - Cile 2
CO - Colombia 2
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
HN - Honduras 2
HU - Ungheria 2
LA - Repubblica Popolare Democratica del Laos 2
PE - Perù 2
RS - Serbia 2
SY - Repubblica araba siriana 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
AD - Andorra 1
AF - Afghanistan, Repubblica islamica di 1
AO - Angola 1
BB - Barbados 1
BG - Bulgaria 1
BO - Bolivia 1
CG - Congo 1
CM - Camerun 1
CR - Costa Rica 1
DM - Dominica 1
DZ - Algeria 1
EG - Egitto 1
ET - Etiopia 1
GA - Gabon 1
GE - Georgia 1
GY - Guiana 1
HR - Croazia 1
KW - Kuwait 1
KZ - Kazakistan 1
LB - Libano 1
LT - Lituania 1
LV - Lettonia 1
MD - Moldavia 1
ME - Montenegro 1
MU - Mauritius 1
NI - Nicaragua 1
NP - Nepal 1
OM - Oman 1
PH - Filippine 1
PS - Palestinian Territory 1
SA - Arabia Saudita 1
SV - El Salvador 1
TW - Taiwan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 6.504
Salva come PNG Salva come JPEG
Città #
Southend 487
Chandler 359
Moscow 347
Singapore 199
Ashburn 177
Dallas 162
Jacksonville 155
Dublin 133
Hong Kong 124
Ann Arbor 108
Beijing 105
Woodbridge 96
New York 55
Wilmington 55
Lawrence 50
Princeton 50
Houston 45
Dong Ket 40
Verona 38
Jinan 36
Redmond 36
Columbus 31
Nanjing 28
Redondo Beach 28
Los Angeles 27
Shenyang 27
The Dalles 24
Seattle 23
Helsinki 21
Council Bluffs 20
Hebei 20
Jakarta 19
São Paulo 19
Brussels 17
Kent 17
Munich 17
Sindelfingen 17
Tianjin 17
Ho Chi Minh City 16
Santa Clara 16
Boardman 15
Ningbo 15
Lancaster 14
Buffalo 13
Rome 13
Taizhou 13
Vienna 13
Changsha 12
Hanoi 12
Tokyo 12
Padova 11
Zhengzhou 11
Brooklyn 10
Denver 10
Jiaxing 10
Seoul 10
Atlanta 9
Nanchang 9
Auburn Hills 8
Guangzhou 8
Haikou 8
Hangzhou 8
Milan 8
Redwood City 8
Rio de Janeiro 8
San Francisco 8
Bologna 7
Chicago 7
London 7
Nuremberg 7
Porto Alegre 7
Quito 7
Taiyuan 7
Turku 7
Ankara 6
Boston 6
Phoenix 6
Venice 6
Washington 6
Biên Hòa 5
Fuzhou 5
Johannesburg 5
Lanzhou 5
Manchester 5
Norwalk 5
Orem 5
Querétaro 5
Turin 5
Warsaw 5
Cambridge 4
Chennai 4
Esslingen am Neckar 4
Foggia 4
Frankfurt am Main 4
Genova 4
Kochi 4
Mexico City 4
Montreal 4
San Jose 4
Stockholm 4
Totale 3.717
Salva come PNG Salva come JPEG
Nome #
DISREGOLAZIONE DELLA BIOSINTESI E DEL METABOLISMO DEI PROTEOGLICANI/GLICOSAMINOGLICANI NEI SOGGETTI UREMICI: UNO STUDIO DI GENOMICA FUNZIONALE 227
Eparanasi: un nuovo biomarker di fibrosi e un potenziale target farmacologico per ridurre la progressione del danno renale cronico 220
IDENTIFICATION OF MOLECULAR BIOMARKERS FOR EARLY DIAGNOSIS OF DELAYED GRAFT FUNCTION IN RENAL TRANSPLANT RECIPIENTS 171
A specific immune transcriptomic profile discriminates chronic kidney disease patients in predialysis from hemodialyzed patients. 168
IDENTIFICAZIONE DI BIOMARCATORI MOLECOLARI PER LA DIAGNOSI PRECOCE DELLA FUNZIONALITÀ RITARDATA DELL'ORGANO TRAPIANTATO 161
mTOR inhibitors and renal allograft: Yin and Yang. 160
Proteomic-based research strategy identified laminin subunit alpha 2 as a potential urinary-specific biomarker for the medullary sponge kidney disease. 159
In Vitro Identification of New Transcriptomic and miRNomic Profiles Associated with Pulmonary Fibrosis Induced by High Doses Everolimus: Looking for New Pathogenetic Markers and Therapeutic Targets. 159
NLRP3 Inflammasome Activation in Dialyzed Chronic Kidney Disease Patients. 156
Comparative transcriptome analysis of peripheral blood mononuclear cells in renal transplant recipients in everolimus- and tacrolimus-based immunosuppressive therapy 154
Downregulation of nuclear-encoded genes of oxidative metabolism in dialyzed chronic kidney disease patients. 153
Extra-renal adverse effects of mTOR inhibitors: know them to optimize their use in renal transplantation. 151
Specific heparanase inhibition reverses glucose-induced mesothelial-to-mesenchymal transition. 151
Everolimus-induced epithelial to mesenchymal transition (EMT) in bronchial/pulmonary cells: when the dosage does matter in transplantation 151
Emotional symptoms, quality of life and cytokine profile in hemodialysis patients. 148
DISTURBI PSICOLOGICI, QUALITÀ DI VITA E PRODUZIONE DI CITOCHINE NEI PAZIENTI IN EMODIALISI 148
Monoclonal antibody therapy and renal transplantation: focus on adverse effects. 147
Sirolimus and Everolimus Pathway: Reviewing Candidate Genes Influencing Their Intracellular Effects 146
Impact of maintenance immunosuppressive therapy on the fecal microbiome of renal transplant recipients: Comparison between an everolimus- and a standard tacrolimus-based regimen. 145
How has peritoneal dialysis changed over the last 30 years: experience of the Verona dialysis center 142
Everolimus-induced epithelial to mesenchymal transition in immortalized human renal proximal tubular epithelial cells: key role of heparanase. 138
Dialysis-related systemic microinflammation is associated with specific genomic patterns 136
Proteomic Analysis of Urinary Microvesicles and Exosomes in Medullary Sponge Kidney Disease and Autosomal Dominant Polycystic Kidney Disease. 135
Sulodexide alone or in combination with low doses of everolimus inhibits the hypoxia-mediated epithelial to mesenchymal transition in human renal proximal tubular cells. 133
Sphingomyelin and medullary sponge kidney disease: a biological link identified by omics approach 132
Personalization of the Immunosuppressive Treatment in Renal Transplant Recipients: The Great Challenge in "Omics" Medicine. 131
Systemic and Nonrenal Adverse Effects Occurring in Renal Transplant Patients Treated with mTOR Inhibitors. 130
Pharmacogenetics: a promising tool to personalize immunosuppressive therapy in renal transplantation. 128
Mitochondria: a new therapeutic target in chronic kidney disease. 127
Transcriptomics: A Step behind the Comprehension of the Polygenic Influence on Oxidative Stress, Immune Deregulation, and Mitochondrial Dysfunction in Chronic Kidney Disease. 127
mTOR Inhibition Role in Cellular Mechanisms 126
Heparanase regulates the M1 polarization of renal macrophages and their crosstalk with renal epithelial tubular cells after ischemia/reperfusion injury 125
Dialysis-related transcriptomic profiling: The pivotal role of heparanase. 123
Karyopherins: potential biological elements involved in the delayed graft function in renal transplant recipients. 122
Hypomethylation of NLRP3 gene promoter discriminates glucocorticoid-resistant from glucocorticoid-sensitive idiopathic nephrotic syndrome patients 120
High-Dose Everolimus May Induce Pro-Inflammatory/Fibrotic Transcriptomic Changes in Bronchial Epithelial Cells from Cystic Fibrosis Patients 120
From pharmacogenetics to pharmacogenomics: the birth of a new era of personalized medicine in nephrology 119
In vitro effects of interleukin (IL)-1 beta inhibition on the epithelial-to-mesenchymal transition (EMT) of renal tubular and hepatic stellate cells. 119
The Genetic Architecture of Membranous Nephropathy and Its Potential to Improve Non-Invasive Diagnosis 119
Sclerostin and Dickkopf-1 in post-menopausal renal allograft recipients. 118
Naturally Occurring Compounds: New Potential Weapons against Oxidative Stress in Chronic Kidney Disease. 112
Analysis of urinary exosomes applications for rare kidney disorders. 112
Inhibition of heparanase protects against chronic kidney dysfunction following ischemia/reperfusion injury. 101
Proteomic Analysis of Urinary Extracellular Vesicles Reveals a Role for the Complement System in Medullary Sponge Kidney Disease 96
PNPLA3 I148M gene variant and chronic kidney disease in type 2 diabetic patients with NAFLD: Clinical and experimental findings 92
Mitochondrial dysregulation and oxidative stress in patients with chronic kidney disease 89
Pharmacogenomics: a new paradigm to personalize treatments in nephrology patients. 88
Kidney Allograft Fibrosis: What We Learned From Latest Translational Research Studies 82
Recent Advances in the Role of Natural Killer Cells in Acute Kidney Injury 64
Proteomic profile of mesothelial exosomes isolated from peritoneal dialysis effluent of children with focal segmental glomerulosclerosis 59
Totale 6.640
Salva come PNG Salva come JPEG
Categoria #
all - tutte 22.674
article - articoli 20.718
book - libri 0
conference - conferenze 1.956
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.348
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021262 0 0 0 0 55 34 16 19 4 6 40 88
2021/2022399 25 76 11 67 8 17 28 31 12 9 25 90
2022/20231.002 62 140 83 172 85 228 8 51 119 6 32 16
2023/2024450 23 39 49 40 57 81 9 40 3 10 82 17
2024/20251.054 52 67 47 202 49 37 68 52 152 50 98 180
2025/20261.879 225 136 173 561 784 0 0 0 0 0 0 0
Totale 6.640